跳至主要内容
临床试验/NCT02120443
NCT02120443已完成不适用

ivWatch Model 400: Device Validation for Non-Infiltrated Tissues

ivWatch, LLC1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2014年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
ivWatch, LLC
入组人数
43
试验地点
1
主要终点
Normal Tissue Red Notification Rate

研究概览

简要总结

A single arm study of 40 adult volunteers to assess the safety and efficacy of the ivWatch Model 400 when observing non-infiltrated (normal) tissues at common peripheral IV therapy sites.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Informed consent
  • •Pass health screen
  • •18 years or older

排除标准

  • •Fail health screen

研究组 & 干预措施

Non-Infiltrated Tissue

Experimental

The ivWatch Model 400 monitored a common peripheral IV site over a 24 hour observation period.

干预措施: ivWatch Model 400 (Device)

结局指标

主要结局

Normal Tissue Red Notification Rate

时间窗: 24 hours

The ivWatch Model 400 issues red notifications to communicate the need for a clinician to check an IV site. A red notification suggests an increased likelihood that an IV infiltration may be occurring, with a greater likelihood relative to a yellow notification. This measure describes the average number of red notifications issued by the ivWatch device in a given day when monitoring normal, non-infiltrated tissues. The 95% confidence interval for the red notification rate was calculated using the Clopper-Pearson method.

次要结局

  • Normal Tissue Yellow Notification Rate(24 hours)
  • Significant Skin Irritation or Disruption to Skin Integrity(24 hours)

研究者

发起方
ivWatch, LLC
申办方类型
Industry
责任方
Principal Investigator
主要研究者

Garret Bonnema

Chief Science Officer

ivWatch, LLC

研究点 (1)

Loading locations...

相似试验